parkinson glutathione oxidative ipsc crispr Frontiers Using iPS Cells toward the
Using iPS Cells toward the Understanding of Parkinson's Disease Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Journal of Molecular Medicine Springer Nature Link Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses Cell Research
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21




